bumetanide has been researched along with Acidosis, Diabetic in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bumetanide treatment increased ATP/Pi and PCr/Pi and ameliorated the declines in these values with insulin/saline treatment." | 5.36 | Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. ( Anderson, SE; Glaser, N; O'Donnell, ME; Tancredi, DJ; Yuen, N, 2010) |
| "The mechanisms responsible for cerebral edema formation in diabetic ketoacidosis (DKA) are not well understood, although evidence suggests ischemia as a contributing factor." | 5.33 | Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. ( Anderson, SE; Glaser, N; Lam, TI; O'Donnell, ME, 2005) |
| "Treatment with bumetanide did not significantly alter OX42 or GFAP intensity." | 1.46 | Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain. ( Cohen, M; Glaser, N; Little, C; Lo, W; O'Donnell, M; Tancredi, D; Wulff, H, 2017) |
| "Bumetanide treatment increased ATP/Pi and PCr/Pi and ameliorated the declines in these values with insulin/saline treatment." | 1.36 | Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. ( Anderson, SE; Glaser, N; O'Donnell, ME; Tancredi, DJ; Yuen, N, 2010) |
| "The mechanisms responsible for cerebral edema formation in diabetic ketoacidosis (DKA) are not well understood, although evidence suggests ischemia as a contributing factor." | 1.33 | Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. ( Anderson, SE; Glaser, N; Lam, TI; O'Donnell, ME, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaser, N | 4 |
| Little, C | 1 |
| Lo, W | 1 |
| Cohen, M | 1 |
| Tancredi, D | 1 |
| Wulff, H | 1 |
| O'Donnell, M | 1 |
| Yuen, N | 2 |
| Anderson, SE | 3 |
| Tancredi, DJ | 2 |
| O'Donnell, ME | 3 |
| Lam, TI | 1 |
4 other studies available for bumetanide and Acidosis, Diabetic
| Article | Year |
|---|---|
Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Brain; Bumetanide; CD11b Antigen; Cere | 2017 |
Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis.
Topics: Animals; Brain Edema; Bumetanide; Cerebrovascular Circulation; Diabetic Ketoacidosis; Magnetic Reson | 2008 |
Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide.
Topics: Animals; Aspartic Acid; Brain; Brain Edema; Bumetanide; Cerebrovascular Circulation; Creatinine; Dia | 2010 |
Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Brain Edema; Bumetanide; Carbon Dioxide; Diabetic Ketoa | 2005 |